Enzo Biochem (ENZ)

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	57.16 mm	57.16 mm	57.16 mm	57.16 mm	57.16 mm	57.16 mm
Cash burn (monthly)	1.03 mm	(no burn)	710.33 k	1.57 mm	954.00 k	3.52 mm
Cash used (since last report)	4.41 mm	n/a	3.04 mm	6.74 mm	4.09 mm	15.07 mm
Cash remaining	52.75 mm	n/a	54.11 mm	50.42 mm	53.07 mm	42.08 mm
Runway (months of cash)	51.3	n/a	76.2	32.1	55.6	12.0

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q1 2024

ENZ institutional ownership history Ownership history

16.8% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	14	9	+55.6%
Opened positions	7	1	+600.0%
Closed positions	2	35	-94.3%
Increased positions	0	0
Reduced positions	1	1	–

13F shares	Current	Prev Q	Change
Total value	252.07 mm	203.09 mm	+24.1%
Total shares	8.66 mm	8.69 mm	-0.3%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Harbert Discovery Fund	5.18 mm	$17.03 mm	0.0%
1 Main Capital Management	2.87 mm	$4.46 mm	0.0%
Radoff Bradley Louis	430.00 k	$512.00 k	0.0%
Wittenberg Investment Management	68.00 k	$86.36 mm	NEW
Kempner Capital Management	25.48 k	$32.00 mm	0.0%
Assenagon Asset Management	19.77 k	$25.11 mm	-72.7%
PFG Investments	18.66 k	$23.70 mm	NEW
Raymond James Trust N.a.	17.02 k	$21.61 mm	0.0%
Shulman DeMeo Asset Management	15.49 k	$19.67 mm	0.0%
Sage Mountain Advisors	14.20 k	$18.03 mm	NEW

Largest transactions	Shares	Bought/sold	Change
FNY Investment Advisers	0.00	-75.91 k	EXIT
Wittenberg Investment Management	68.00 k	+68.00 k	NEW
Assenagon Asset Management	19.77 k	-52.64 k	-72.7%
PFG Investments	18.66 k	+18.66 k	NEW
Sage Mountain Advisors	14.20 k	+14.20 k	NEW
BFSG	2.81 k	+2.81 k	NEW
Simplex Trading	881.00	+881.00	NEW
Benjamin Edwards	300.00	+300.00	NEW
Focused Wealth Management	0.00	-110.00	EXIT
Sound Income Strategies	10.00	+10.00	NEW

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

ENZ insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
24 Jul 24	Kara Cannon	Common Stock	Payment of exercise	Dispose F	No	No	1.17	70,885	82.94 k	380,412
24 Jul 24	Patricia Eckert	Stock Option (to acquire shares of Common Stock) Common Stock	Grant	Acquire A	No	No	2	100,000	200.00 k	100,000
23 May 24	Kara Cannon	Stock Option (to acquire shares of Common Stock) Common Stock	Grant	Acquire A	No	No	2	200,000	400.00 k	200,000
23 Feb 24	Patricia Eckert	Stock Option (to acquire shares of Common Stock) Common Stock	Grant	Acquire A	No	No	1.38	75,000	103.50 k	75,000
23 Feb 24	Kara Cannon	Common Stock	Grant	Acquire A	No	No	0	150,000	0.00	451,297
21 Feb 24	Kara Cannon	Common Stock	Payment of exercise	Dispose F	No	No	0	5,823	0.00	301,297
21 Feb 24	Kara Cannon	Common Stock	Option exercise	Acquire M	No	No	0	10,640	0.00	307,120

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

Press releases

From Benzinga Pro

Enzo Biochem Reports Third Quarter Fiscal 2024 Results and Provides Business Update

13 Jun 24

FARMINGDALE, N.Y., June 13, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) ("Enzo" or the "Company") today announced financial results for the fiscal third quarter ended April 30, 2024. Third Quarter